• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Survey: Most Physicians Fail to Share Prescribed Medication Costs with Their Patients

by Jasmine Pennic 11/09/2018 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Opioid Prescriptions_Prescribed Medication Costs

New DrFirst survey reveals almost 75% of consumers would change pharmacies to save money, yet the majority of physicians do not provide price information.

With medication adherence being a critical factor in patients’ long-term health, physicians are under increasing pressure to discuss costs with patients when they write prescriptions. Yet according to a recent DrFirst survey, fewer than half (44%) of consumers say their physician advised them about medication costs or offered lower-cost therapeutic alternatives.

Survey Background

Respondents to the online survey of 200 consumers were nearly evenly divided between male (50.5%) and female (49.5%). Eighty-seven percent reported having health insurance. The largest age group represented was between 25 and 34 years old (27%), followed by 35-44 (23%) and over 54 (23%).  Respondents were pre-selected for having filled at least one prescription in the last year. They tend to be heavy users of prescription medications. Sixty-two percent reported filling a prescription once each month, while 23% do so once every 3-4 months, and 14% fill an order every week.

Key Findings

At a time when the federal government is pushing a variety of measures to make prescription drug prices more transparent to consumers, the survey finds that fully 73 percent of consumers would change pharmacies if they knew that doing so would save them money on a prescription.

Even fewer (41%) reported receiving advice from their doctor or pharmacist about possible cost-saving coupons or having a prescription filled at a less-expensive pharmacy. Respondents’ willingness to change pharmacies to save money indicates that such advanced notice of prescription costs, coupon options, or lower-cost pharmacies would be highly valuable.

As Little as $10 in Savings Motivates Consumers

The survey finds that as little as $10 in savings would motivate 38 percent of respondents to switch pharmacies. If the savings rose to between $11 and $25, nearly 70 percent of them would choose a different pharmacy. The survey results are consistent with recent studies that found a high correlation between drug costs and medication adherence, or the likelihood that patients will follow their doctor’s prescribed therapy. 

Addressing High Drug Prices & Price Transparency

Addressing high drug prices and increasing price transparency is a priority for the Trump administration, and Congress, which passed two bills recently that prohibit pharmacy gag clauses on drug prices. The legislation allows pharmacists to tell customers when they could save money by paying for a prescription out-of-pocket instead of using insurance and paying their copay amount. Results from the DrFirst survey, however, indicate that participants would like notification about drug pricing options before picking up prescriptions. 

“Physicians must be sensitive to the fact that even a $10 price difference influences patient behavior when it comes to filling prescriptions,” said G. Cameron Deemer, president of DrFirst. “The survey underscores patients’ desire to have pricing information up-front, before going to the pharmacy. To reduce prescription abandonment and improve health outcomes, physicians must actively participate in this conversation at the point of prescribing so that the physician and patient can jointly decide on the best medication option.”

 

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: DrFirst Interoperability, Drug-Price Transparency

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Kinetik CEO Sufian Chowdhury on Fighting NEMT Fraud & Waste

Most-Read

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

WeightWatchers Files for Bankruptcy to Eliminate $1.15B in Debt

WeightWatchers Files for Bankruptcy to Eliminate $1.15B in Debt

KLAS: Epic Dominates 2024 EHR Market Share Amid Focus on Vendor Partnership; Oracle Health Sees Losses Despite Tech Advances

KLAS: Epic Dominates 2024 EHR Market Share Amid Focus on Vendor Partnership; Oracle Health Sees Losses Despite Tech Advances

'Cranky Index' Reveals EHR Alert Frustration Peaks Midweek, Highest Among Admin Staff

‘Cranky Index’ Reveals EHR Alert Frustration Peaks Midweek, Highest Among Admin Staff

Madison Dearborn Partners to Acquire Significant Stake in NextGen Healthcare

Madison Dearborn Partners to Acquire Significant Stake in NextGen Healthcare

Wandercraft Begins Clinical Trials for Physical AI-Powered Personal Exoskeleton

Wandercraft Begins Clinical Trials for Physical AI-Powered Personal Exoskeleton

Chipiron Secures $17M to Transform MRI Access with Portable Scanner

Chipiron Secures $17M to Transform MRI Access with Portable Scanner

Abbott to Integrate FreeStyle Libre Glucose Data with Epic EHR

Abbott to Integrate FreeStyle Libre Glucose Data with Epic EHR

5 Ways New Trump Administration Tariffs Are Impacting U.S. Healthcare Now

5 Ways Trump Administration Tariffs Are Impacting U.S. Healthcare Now

iCAD, GE HealthCare Integrate to Advance Breast Cancer Detection with AI

RadNet to Acquire iCAD for $103M in All-Stock Transaction

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |